Literature DB >> 12644314

Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes.

Piyali Mukherjee1, Asish K Ghosh, Asoke C Ghose.   

Abstract

Intracardial inoculation of BALB/c mice with Leishmania donovani amastigotes induced progressive visceral leishmaniasis (VL) with increasing splenic parasite load when followed upto 4-month postinfection period. In contrast, the liver parasite load reached maximum around 2-month postinfection period following which it started declining. The infection pattern differed somewhat from the earlier reports on mouse model of VL induced by intravenous inoculation of parasites with respect to the duration as well as magnitude of parasite burden in the organs (liver and spleen) and associated hepatosplenomegaly. Immunosuppression in mice with progressive VL was manifested in the form of impairment of proliferative response of the splenic mononuclear cells (SPMC) to in vitro stimulation with leishmanial antigen or the mitogen concanavalin A (ConA), although ConA stimulated cells were found to be capable of IL-2 and IFN-gamma synthesis. Differential expression of activating (IL-2, IFN-gamma and TNF-alpha) as well as deactivating (IL-4 and TGF-beta) cytokines was demonstrable in the spleen and liver of animals during the course of infection. Further, the synthesis of inducible nitric oxide synthase (iNOS) enzyme increased considerably in the liver as well as in the spleen of 4-month infected animal with parallel increase in the transcripts of the iNOS activating cytokines IFN-gamma and TNF-alpha. The temporal variation in the organ specific immune response could be related to the differential control of parasite burden in the liver and spleen of the infected host.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644314     DOI: 10.1016/s0165-2478(03)00021-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  16 in total

1.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Kathleen C Flanders; Debra D Donaldson; Joseph P Sypek; Philip J Gotwals; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds.

Authors:  M A Dea-Ayuela; S Rama-Iñiguez; J M Alunda; F Bolás-Fernandez
Journal:  Vet Res Commun       Date:  2007-01-19       Impact factor: 2.459

3.  Role of IL-21 in host pathogenesis in experimental visceral leishmaniasis.

Authors:  R Khatonier; A M Khan; P Sarmah; G U Ahmed
Journal:  J Parasit Dis       Date:  2018-08-22

4.  Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.

Authors:  Eline Eberhardt; Annelies Mondelaers; Sarah Hendrickx; Magali Van den Kerkhof; Louis Maes; Guy Caljon
Journal:  Parasitol Res       Date:  2016-07-13       Impact factor: 2.289

5.  Evaluation of TNF-α, IL-4, and IL-10 and parasite density in spleen and liver of L. (L.) chagasi naturally infected dogs.

Authors:  A DE F Michelin; S H V Perri; V M F De Lima
Journal:  Ann Trop Med Parasitol       Date:  2011-07

6.  Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites.

Authors:  Dulcilene M Oliveira; Mariana Amália F Costa; Miguel A Chavez-Fumagalli; Diogo G Valadares; Mariana C Duarte; Lourena E Costa; Vivian T Martins; Rosângela F Gomes; Maria N Melo; Manuel Soto; Carlos Alberto P Tavares; Eduardo Antonio F Coelho
Journal:  Parasitol Res       Date:  2011-09-14       Impact factor: 2.289

7.  Does Leishmaniasis disease alter the parenchyma and protein expression in salivary glands?

Authors:  Aírton M C Júnior; Fernando A de Amorim Carvalho; Weslany de Oliveira Dantas; Luana C L Gomes; Andrezza B S da Silva; Maria M A de Sousa Cavalcante; Ingrid M de Oliveira; Marina de Deus Moura de Lima; Márcia Dos Santos Rizzo; Carla Maria de Carvalho Leite; Selma Maria Dos Santos Moura; Lúcia de Fátima Almeida de Deus Moura; Benedito B da Silva
Journal:  Exp Biol Med (Maywood)       Date:  2015-11-13

8.  TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis.

Authors:  Subir Karmakar; Siddhartha Kumar Bhaumik; Joydeep Paul; Tripti De
Journal:  PLoS Pathog       Date:  2012-04-12       Impact factor: 6.823

9.  Systems infection biology: a compartmentalized immune network of pig spleen challenged with Haemophilus parasuis.

Authors:  Ming Zhao; Xiang-dong Liu; Xin-yun Li; Hong-bo Chen; Hui Jin; Rui Zhou; Meng-jin Zhu; Shu-hong Zhao
Journal:  BMC Genomics       Date:  2013-01-22       Impact factor: 3.969

10.  Functional analysis of Leishmania cyclopropane fatty acid synthetase.

Authors:  Samuel O Oyola; Krystal J Evans; Terry K Smith; Barbara A Smith; James D Hilley; Jeremy C Mottram; Paul M Kaye; Deborah F Smith
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.